{
    "id": 30721,
    "fullName": "MET R1004G",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "MET R1004G lies within the cytoplasmic domain of the Met protein (UniProt.org). R1004G has been identified in the scientific literature (PMID: 31391294), but has not been biochemically characterized and therefore, its effect on Met protein function is unknown (PubMed, Mar 2020).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 15994,
                    "pubMedId": 31391294,
                    "title": "MET Genomic Alterations in Head and Neck Squamous Cell Carcinoma (HNSCC): Rapid Response to Crizotinib in a Patient with HNSCC with a Novel MET R1004G Mutation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31391294"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4233,
        "geneSymbol": "MET",
        "terms": [
            "MET",
            "AUTS9",
            "c-Met",
            "DFNB97",
            "HGFR",
            "RCCP2"
        ]
    },
    "variant": "R1004G",
    "createDate": "08/15/2019",
    "updateDate": "03/13/2020",
    "referenceTranscriptCoordinates": {
        "id": 182015,
        "transcript": "NM_000245",
        "gDna": "chr7:g.116771971C>G",
        "cDna": "c.3010C>G",
        "protein": "p.R1004G",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 18094,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, Xalkori (crizotinib) treatment resulted in rapid clinical response in a patient with oral cavity squamous cell carcinoma harboring MET R1004G (PMID: 31391294).",
            "molecularProfile": {
                "id": 32961,
                "profileName": "MET R1004G"
            },
            "therapy": {
                "id": 706,
                "therapyName": "Crizotinib",
                "synonyms": null
            },
            "indication": {
                "id": 50866,
                "name": "oral squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 15994,
                    "pubMedId": 31391294,
                    "title": "MET Genomic Alterations in Head and Neck Squamous Cell Carcinoma (HNSCC): Rapid Response to Crizotinib in a Patient with HNSCC with a Novel MET R1004G Mutation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31391294"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 32961,
            "profileName": "MET R1004G",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 182015,
            "transcript": "NM_000245",
            "gDna": "chr7:g.116771971C>G",
            "cDna": "c.3010C>G",
            "protein": "p.R1004G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}